406 related articles for article (PubMed ID: 17883836)
41. A rational approach to maximize success rate in target discovery.
Schneider M
Arch Pharm (Weinheim); 2004 Dec; 337(12):625-33. PubMed ID: 15597396
[TBL] [Abstract][Full Text] [Related]
42. A method for protein accessibility prediction based on residue types and conformational states.
Zarei R; Arab S; Sadeghi M
Comput Biol Chem; 2007 Oct; 31(5-6):384-8. PubMed ID: 17888743
[TBL] [Abstract][Full Text] [Related]
43. Assessing potential miRNA targets based on a Markov model.
Fu HY; Xue DY; Zhang XD; Yang PY
Genet Mol Res; 2009 Jul; 8(3):848-60. PubMed ID: 19731207
[TBL] [Abstract][Full Text] [Related]
44. Biocomputational strategies for microbial drug target identification.
Sakharkar KR; Sakharkar MK; Chow VT
Methods Mol Med; 2008; 142():1-9. PubMed ID: 18437301
[TBL] [Abstract][Full Text] [Related]
45. High accuracy template based modeling by global optimization.
Joo K; Lee J; Lee S; Seo JH; Lee SJ; Lee J
Proteins; 2007; 69 Suppl 8():83-9. PubMed ID: 17894332
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
Frye SV
Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
[TBL] [Abstract][Full Text] [Related]
47. Evaluating the absolute quality of a single protein model using structural features and support vector machines.
Wang Z; Tegge AN; Cheng J
Proteins; 2009 May; 75(3):638-47. PubMed ID: 19004001
[TBL] [Abstract][Full Text] [Related]
48. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
49. Strategies and methods in the identification of antagonists of protein-protein interactions.
Gadek TR
Biotechniques; 2003 Jun; Suppl():21-4. PubMed ID: 12813901
[TBL] [Abstract][Full Text] [Related]
50. Assessment of predictions submitted for the CASP7 domain prediction category.
Tress M; Cheng J; Baldi P; Joo K; Lee J; Seo JH; Lee J; Baker D; Chivian D; Kim D; Ezkurdia I
Proteins; 2007; 69 Suppl 8():137-51. PubMed ID: 17680686
[TBL] [Abstract][Full Text] [Related]
51. The target discovery process.
Egner U; Krätzschmar J; Kreft B; Pohlenz HD; Schneider M
Chembiochem; 2005 Mar; 6(3):468-79. PubMed ID: 15742383
[TBL] [Abstract][Full Text] [Related]
52. Identification of catalytic residues from protein structure using support vector machine with sequence and structural features.
Pugalenthi G; Kumar KK; Suganthan PN; Gangal R
Biochem Biophys Res Commun; 2008 Mar; 367(3):630-4. PubMed ID: 18206645
[TBL] [Abstract][Full Text] [Related]
53. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
Trawick JD; Schilling CH
Biochem Pharmacol; 2006 Mar; 71(7):1026-35. PubMed ID: 16329998
[TBL] [Abstract][Full Text] [Related]
54. PRINTR: prediction of RNA binding sites in proteins using SVM and profiles.
Wang Y; Xue Z; Shen G; Xu J
Amino Acids; 2008 Aug; 35(2):295-302. PubMed ID: 18235992
[TBL] [Abstract][Full Text] [Related]
55. How accurately can we discriminate G-protein-coupled receptors as 7-tms TM protein sequences from other sequences?
Inoue Y; Yamazaki Y; Shimizu T
Biochem Biophys Res Commun; 2005 Dec; 338(3):1542-6. PubMed ID: 16274668
[TBL] [Abstract][Full Text] [Related]
56. Detecting drug targets with minimum side effects in metabolic networks.
Li Z; Wang RS; Zhang XS; Chen L
IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
[TBL] [Abstract][Full Text] [Related]
57. Industrial perspective on X-ray data collection and analysis.
Skarzynski T; Thorpe J
Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):102-7. PubMed ID: 16369099
[TBL] [Abstract][Full Text] [Related]
58. Predicting drug targets based on protein domains.
Wang YY; Nacher JC; Zhao XM
Mol Biosyst; 2012 Apr; 8(5):1528-34. PubMed ID: 22402667
[TBL] [Abstract][Full Text] [Related]
59. Noise reduction method for molecular interaction energy: application to in silico drug screening and in silico target protein screening.
Fukunishi Y; Kubota S; Nakamura H
J Chem Inf Model; 2006; 46(5):2071-84. PubMed ID: 16995738
[TBL] [Abstract][Full Text] [Related]
60. Progress and problems in the exploration of therapeutic targets.
Zheng C; Han L; Yap CW; Xie B; Chen Y
Drug Discov Today; 2006 May; 11(9-10):412-20. PubMed ID: 16635803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
